我要投票 广济药业在饲料添加剂行业中的票数:348
· 外 推 电 报 ·
2025-08-04 03:14:59 星期一

【广济药业是哪个国家的品牌?】

广济药业是什么牌子?「广济药业」是 湖北广济药业股份有限公司 旗下著名品牌。该品牌发源于湖北,由创始人安靖在1993-05-28期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力广济药业品牌出海!将品牌入驻外推网,定制广济药业品牌推广信息,可以显著提高广济药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

湖北广济药业股份有限公司始建于1969年,是以生产、销售医药原料药及制剂、食品添加剂、饲料添加剂为主的国家重点高新技术企业,1999年在深交所上市(股票代码000952)。

公司曾获全国“五一劳动奖状”,是国家人事部“博士后科研工作站”、国家科技部认定的“火炬计划”重点高新技术企业并被授予“国际科技合作基地”,国家发改委认定的“高新技术成果示范基地”,并承担了国家“863计划”《微生物转化植物甾醇生产雄烯二酮(AD)和雄二烯二酮(ADD)工业化生产工艺开发研究》科研项目;公司先后被湖北省发改委、财政厅、税务局、武汉海关联合授予“省级企业技术中心”;被中国饲料工业协会评为“全国饲料添加剂科技创新优秀企业”、“全国五十强饲料企业”;荣获上市公司市值管理百佳奖,跻身“深证100指数”样本公司,被省政府授予“湖北外贸企业百强”称号,被省人大列为全省立法工作基层联系点,董事长何谧当选为湖北省生物医药产业发展专家咨询委员会委员。

公司立足高新技术,坚持走自主创新之路。通过“引进、消化、吸收、提高、创新”,主导产品核黄素(即维生素B2)得以做强做大,产、销量居世界第一,树立起民族VB工业的强势品牌。核黄素高产菌株工业化大生产技术获国家进步二等奖,湖北省科技进步一等奖,被专家评定为“国际首创”技术,并被国家商务部列入禁止出口技术目录;自主开发的“核黄素清汤发酵技术”经省科技厅鉴定为“达到国际先进水平”,获湖北省科技进步二等奖;β-胡萝卜素技术达到国际先进水平,2009年公司与华中科技大学合作成立了产学研合作基地。

公司立足环保治理,实现节能减排。先后投资2600万元建成日处理2500吨污水的污水处理厂;投资4000多万元建成多效蒸发装置,废水经处理后实现达标排放;投入5000万元用35吨循环流化床锅炉代替4台小锅炉,年节煤1.38万吨;采用布袋除尘使烟尘排放量控制50mg/m3以下,采用新型发酵电机,年节电达2000多万度,被国家发改委列为资源节约和环境保护国债项目。

公司注重产品质量体系建设,公司产品六条生产线全部通过国家GMP认证,核黄素生产遵循国际标准,通过了国际ISO9001(国际质量管理体系标准)、HACCP(联合国食品法典委员会推荐的预防性的食品安全卫生控制体系)、ISO14001(国际环境管理体系标准)认证,并通过了FAMI-QS(欧盟有关饲料添加剂和预混饲料添加剂质量管理规范)、ISO22000(食品安全管理体系)认证。公司注重品牌建设。“广济业”和“JIVITA”商标不仅在国内注册,而且“JIVITA”商标在香港、美国和欧盟获得注册;“”商标评为湖北省著名商标,饲料添加剂维生素B2被评为湖北省出口名牌产品,被国家饲料协会评为信得过产品;“”牌饲料级维生素被评为“中国名牌”产品。

公司现有总资产13.9亿元,员工1145人(其中执业药师15人,工程技术人员256人)。为培育新的利润增长点,进一步增强综合竞争实力,公司计划征地1800亩,建设“广济药业生物产业园”,计划建设期为6~8年,计划总投资25~30亿元,重点投资建设维生素、氨基酸、甾体药物等类项目,投资将分步、分期进行。2010年,公司与两家合作伙伴共同投资成立湖北惠生药业有限公司,建设年产1000吨维生素B6扩建项目。

进入“广济药业后时代”的2010年乃至今后很长一段时间内,公司工作的总体思路与奋斗目标是:“再展宏图开创广济药业后时代,低碳发展恪守“四大”(大智慧、大手笔、大勇气、大魄力)、“三高”(高质量、高品位、高附加值)新理念,自主创新提升企业核心竞争力,服务世界争进“医药行业五十强”。公司将在科学发展观的指引下,力争建成主导产品在技术上达到世界领先水平、具有较强国际竞争力的生物制药企业。

英文翻译:Hubei Guangji Pharmaceutical Co., Ltd., founded in 1969, is a national key high-tech enterprise mainly engaged in the production and sale of pharmaceutical raw materials and preparations, food additives and feed additives. It was listed on Shenzhen Stock Exchange in 1999 (Stock Code: 000952). The company has won the national "May 1st Labor Award", is a key high-tech enterprise recognized by the Ministry of personnel "postdoctoral research workstation", the Ministry of science and technology of the people's Republic of China "Torch Plan", and is awarded "international science and technology cooperation base", the national development and Reform Commission "high and new technology achievement demonstration base", and undertakes the national "863 Plan" microbial transformation of phytosterol to produce androstenediol Scientific research project of industrial production process development and research of ketone (AD) and androstenedione (add); the company has been jointly awarded "provincial enterprise technology center" by Hubei Provincial Development and Reform Commission, Department of finance, tax bureau and Wuhan Customs; awarded "national feed additive science and technology innovation excellent enterprise" and "national top 50 feed enterprise" by China Feed Industry Association; won the title of listed company He MI, chairman of the board of directors, was elected as a member of the Expert Advisory Committee for the development of biomedical industry in Hubei Province. Based on high and new technology, the company adheres to the road of independent innovation. Through "introduction, digestion, absorption, improvement and innovation", the leading product riboflavin (i.e. vitamin B2) can be stronger and larger, with its production and sales ranking first in the world, and a strong brand of national VB industry can be established. The industrialized production technology of riboflavin high-yield strains won the second prize of national progress award, the first prize of Hubei Province Science and technology progress award, was evaluated as "international first" technology by experts, and was listed in the catalogue of banned export technology by the Ministry of Commerce of the people's Republic of China; the independently developed "riboflavin clear soup fermentation technology" was identified as "reaching the international advanced level" by the provincial science and Technology Department, and won the second prize of Hubei Province Science and Technology Progress Award; β- Carotene technology has reached the international advanced level. In 2009, the company cooperated with Huazhong University of science and technology to establish a production university research cooperation base. Based on environmental protection, the company realizes energy conservation and emission reduction. It has successively invested 26 million yuan to build a sewage treatment plant with a daily treatment capacity of 2500 tons of sewage, and more than 40 million yuan to build a multi effect evaporation device, so that the wastewater can be discharged up to the standard after treatment; 50 million yuan was invested to replace 4 small boilers with 35 ton circulating fluidized bed boilers, saving 13800 tons of coal annually; bag type dust removal was used to control the emission of smoke and dust below 50mg / m3, and a new type of fermentation motor was used, saving more than 20 million degrees of electricity annually, which was listed as a national debt project of resource conservation and environmental protection by the national development and Reform Commission. The company attaches great importance to the construction of product quality system. All six production lines of the company's products have passed the national GMP certification. Riboflavin production follows the international standards, and has passed the international ISO9001 (international quality management system standards), HACCP (preventive food safety and health control system recommended by the United Nations Food Code Commission), ISO14001 (international environmental management system standards), and passed the It has passed the fami-qs (European Union quality management standard for feed additives and premixed feed additives) and ISO22000 (food safety management system) certification. The company pays attention to brand building. "Guangji industry" and "jivita" trademark are not only registered in China, but also "jivita" trademark is registered in Hong Kong, the United States and the European Union. "" trademark is rated as a famous trademark of Hubei Province, feed additive vitamin B2 is rated as a famous export product of Hubei Province, and is rated as a trustworthy product by the National Feed Association; "brand feed grade vitamin is rated as" China famous brand "product. The company has total assets of 1.39 billion yuan and 1145 employees (including 15 licensed pharmacists and 256 engineering technicians). In order to cultivate a new profit growth point and further enhance the comprehensive competitiveness, the company plans to acquire 1800 mu of land and build a "Guangji pharmaceutical biological industrial park", with a planned construction period of 6-8 years and a total investment of 2.5-3 billion yuan, focusing on the construction of vitamins, amino acids, steroids and other projects. The investment will be carried out step by step and in stages. In 2010, the company and two partners jointly invested and established Hubei Huisheng Pharmaceutical Co., Ltd. to build an annual output of 1000 tons of vitamin B6 expansion project. Entering the "post era of Guangji pharmaceutical industry" in 2010 and for a long time in the future, the company's overall idea and goal of work are: "to further develop the grand plan to create the post era of Guangji pharmaceutical industry, to adhere to the" four major "low-carbon development (big wisdom, big pen, big courage, big courage), the" three high "(high quality, high grade, high added value) new concepts, and to independently innovate and improve the enterprise core Heart competitiveness, serving the world to strive for "top 50 pharmaceutical industry". Under the guidance of the scientific development concept, the company will strive to build a biopharmaceutical enterprise with leading products reaching the world leading level in technology and strong international competitiveness.

本文链接: https://www.waitui.com/brand/7ec6742e1.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中信证券:目前重点关注的依然聚焦在AI、创新药、资源、恒科以及科创板

中信证券研报称,行情的定位决定了主导资金的行为,资金的行为决定了上涨的行业结构及模式。历史上增量流动性驱动的行情中,领涨行业大都是持续集中,而不是高切低轮动;背后的本质是资金对效率的追逐,更倾向于高共识品种,而非在低位品种里“蹲变化”。7月的行情演绎也验证了这一点,行业逐步向趋势性品种聚焦,而高切低模式效率偏低;近期增量流动性边际上有所放缓,行情需要降温才能行稳致远。目前我们重点关注的依然聚焦在AI、创新药、资源、恒科以及科创板。

2小时前

芯导科技:拟4.03亿元购买吉瞬科技100%股权、瞬雷科技17.15%的股权 预计构成重大资产重组

8月3日,芯导科技(688230.SH)公告称,公司拟向盛锋、李晖、黄松、王青松、瞬雷优才发行可转换公司债券及支付现金,购买吉瞬科技100%股权、瞬雷科技17.15%的股权,从而直接及间接持有瞬雷科技100%股权,实现对瞬雷科技的100%控制,交易价格暂定为4.03亿元,本次交易预计构成重大资产重组。瞬雷科技主要从事功率器件的研发、生产和销售;吉瞬科技直接持有瞬雷科技82.85%的股权,仅为瞬雷科技持股主体。

2小时前

过去七天,广东新增2892例基孔肯雅热本地病例

据广东省疾控局消息,2025年7月27日0时至8月2日24时,广东全省新增报告2892例基孔肯雅热本地病例,未报告重症和死亡病例。病例分布在佛山2770例,广州65例,东莞、中山各11例,深圳、江门、肇庆各6例,梅州5例,珠海、惠州各4例,潮州2例,阳江、云浮各1例。

2小时前

银河证券:8月预计市场维持在震荡偏高中枢运行 关注结构性配置机会

8月3日,银河证券研报表示,近期市场行情呈现积极态势,上证指数多次创下年内新高。本轮行情受到流动性和市场预期双重驱动,融资余额自6月底以来持续上行,重返1.9万亿元上方。同时,股市上扬表现带动市场赚钱效应扩散,形成正向反馈。后续关注市场在关键点位附近的支撑力度,8月预计市场维持在震荡偏高中枢运行,关注结构性配置机会。

2小时前

吴声“新物种爆炸2025”:AI场景革命正在让商业开启哲学生活方式周期

8月3日,“新物种爆炸·吴声商业方法发布2025”在京举行。场景实验室创始人、场景方法论提出者吴声表示:AI场景革命正在让商业开启哲学生活方式周期,关键是在每个具体场景重建意义坐标。大会还发布了新物种爆炸2025“意义重建”的八个预测,包括算法休假的AI伦理、从跨境支付到加密生活等。

2小时前

本页详细列出关于广济药业的品牌信息,含品牌所属公司介绍,广济药业所处行业的品牌地位及优势。
咨询